These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 10093660

  • 1. [Guillain-Barré syndrome: from the original description to the modern concepts].
    Raphael JC, Sharshar T, Bourdain F, Léger JM.
    Ann Med Interne (Paris); 1999 Jan; 150(1):33-41. PubMed ID: 10093660
    [Abstract] [Full Text] [Related]

  • 2. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E, Turkay S, Icagasioglu D, Tanzer F, Cevit O.
    Turk J Pediatr; 1996 Jan; 38(1):119-23. PubMed ID: 8819632
    [Abstract] [Full Text] [Related]

  • 3. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA, Bogousslavsky J, Regli F.
    Rev Neurol (Paris); 1991 Jan; 147(8-9):573-6. PubMed ID: 1962066
    [Abstract] [Full Text] [Related]

  • 4. [Guillain-Barré syndrome. Variation on the theme].
    Karlsen B, Vedeler C.
    Tidsskr Nor Laegeforen; 1996 Jan 20; 116(2):242-5. PubMed ID: 8633333
    [Abstract] [Full Text] [Related]

  • 5. Guillain-Barré syndrome: a team approach to diagnosis and treatment.
    Dematteis JA.
    Am Fam Physician; 1996 Jul 20; 54(1):197-200. PubMed ID: 8677835
    [Abstract] [Full Text] [Related]

  • 6. The Guillain-Barré syndrome: diagnosis, treatment and prognosis.
    van der Meché FG.
    Acta Neurol Belg; 1994 Jul 20; 94(2):124-7. PubMed ID: 8036879
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes.
    Uncini A, Yuki N.
    Expert Rev Neurother; 2009 Jun 20; 9(6):869-84. PubMed ID: 19496690
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A, Huerta Villanueva M, Olivé Plana M, Montero Homs J, Serra Catafau J, Martínez-Matos JA.
    Neurologia; 1998 Apr 20; 13(4):166-9. PubMed ID: 9608755
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M, Weinberger M.
    J La State Med Soc; 1998 Nov 20; 150(11):533-7. PubMed ID: 9861805
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.